Stock Price
6.23
Daily Change
-0.23 -3.56%
Monthly
-0.80%
Yearly
60.57%
Q2 Forecast
6.10

Ardelyx reported $381.87M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Amgen USD 31.48B 2.42B Mar/2026
Ardelyx USD 381.87M 447K Mar/2026
aTyr Pharma USD 67.58M 178.23M Mar/2026
Corcept Therapeutics USD 426.03M 59.43M Mar/2026
Curis USD 6.92M 7.5M Dec/2025
Sanofi EUR 30.95B 8.99B Dec/2025
TG Therapeutics USD 1.09B 456.2M Mar/2026
United Therapeutics USD 2.87B 830.5M Mar/2026
Xoma USD 110.71M 5.78M Sep/2025